Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin

Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin

Source: 
Pharmaceutical Business Review
snippet: 

BAT1706 is being developed by Bio-Thera Solutions as a proposed biosimilar to Avastin. The trial demonstrated equivalence in overall response rate (ORR) for the first-line treatment of patients